Qinecsa President Featured in DIA Global Forum Issue

We are proud to announce that Humaira Qureshi, President of Qinecsa Solutions, has been featured in the September 2024 issue of the DIA Global Forum. In her article, titled “A New Pharmacovigilance Ecosystem: Automation, AI, and Continuous Improvement,” Humaira explores the evolution of pharmacovigilance (PV) as it transforms from a reactive, safety-focused function into a […]

Qinecsa Announces World Drug Safety Congress Americas Sponsorship

We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress America 2024! THE LARGEST DRUG SAFETY EVENT IN THE WORLD The World Drug Safety Congress Americas convenes top executives and key stakeholders in the biopharmaceutical sector to address critical issues in drug safety, pharmacovigilance, and medical device safety. Our team […]

What is Pharmacovigilance?

Pharmacovigilance is a critical component of the medicinal product lifecycle, focusing on ensuring the safety and efficacy of medicinal products from pre-clinical development through post-marketing surveillance. The primary goals of pharmacovigilance are to enhance patient safety, manage risks, and strengthen public health and trust in therapeutic products. Regulatory bodies mandate rigorous vigilance to detect and […]

Qinecsa Sponsors the World Drug Safety Congress Europe

We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress Europe 2024, marking our third year! EUROPE’S MOST EXCITING DRUG SAFETY & PV EVENT The World Drug Safety Congress Europe is where key communities and industries come together to discuss the latest advancements in drug safety. From exploring the use […]